Durable biochemical response following adrenal metastasectomy for oligometastatic castrate-resistant prostate cancer
A 77 year-old man was referred to Urology with an enlarging left adrenal mass after treatment with androgen deprivation therapy for metastatic castrate-resistant prostate cancer. He underwent a robotic-assisted left radical adrenalectomy, with pathology revealing metastatic adenocarcinoma consistent...
Main Authors: | Akbar N. Ashrafi, Carlos Fay, Wesley Yip, Daniel M. de Freitas, Jamal Nabhani, Monish Aron |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Urology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214442020301170 |
Similar Items
-
Modern approach in oligometastatic prostate cancer therapy
by: Stanić Jelena, et al.
Published: (2023-01-01) -
Long-term survival after adrenal metastasectomy from colorectal cancer: a report of two cases
by: Akinori Tsujimoto, et al.
Published: (2019-04-01) -
A patient with oligometastatic hormone‐sensitive prostate cancer who achieved long‐term progression‐free survival following cytoreductive radical prostatectomy and metastasectomy
by: Daisuke Mamiya, et al.
Published: (2024-03-01) -
Robotic surgery for malignant and large adrenal masses: A doable and safe option
by: Erdemir Ayhan, et al.
Published: (2023-01-01) -
Brachytherapy for oligometastatic prostate cancer to the penis
by: Nicolas Martz, et al.
Published: (2021-10-01)